PTGX
Protagonist Therapeutics, Inc.
Stock
$140.06+0.87 (+0.63%)Close Oct 2, 2026
Key figures
| Metric | Last 12 months | 5-year CAGR |
|---|---|---|
| Revenue | $282M | +10.0% |
| Operating income | $58M | — |
| Net income | $83M | — |
| EPS | $1.03 | — |
| Free cash flow | $131M | — |
Protagonist Therapeutics, Inc.
$140.06+0.87 (+0.63%)Close Oct 2, 2026
| Metric | Last 12 months | 5-year CAGR |
|---|---|---|
| Revenue | $282M | +10.0% |
| Operating income | $58M | — |
| Net income | $83M | — |
| EPS | $1.03 | — |
| Free cash flow | $131M | — |